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Background
Little is known about the role of different HLA class I alle-
les in the control of HIV-1 CRF01_AE infections, which
dominate in South and Southeast Asia, or the CD8+ T-cell
responses that might be mediating this effect.
Methods
We studied a cohort of 250 chronically HIV-1 infected,
HAART naïve individuals in Bangkok, Thailand. Viral load
and CD4 data were collected for all individuals as well as
4-digit HLA typing and viral sequences. A comprehensive
screen of CD8+ T-cell responses was conducted using an
IFN-gamma ELISpot assay and overlapping clade AE-spe-
cific peptides (OLP) spanning the entire HIV-1 proteome.
Results
Of HLA alleles previously associated with control, namely
B5701, B27, B51 and B1302, only HLA-B1302 was associ-
ated with significantly lower viral loads (n = 14, p = 0.029,
q = 0.115) and with HIV-1 'controllers' (VL<2000/ml; p =
0.016). In examining which CD8 responses might be
mediating this protective effect, we found that the major-
ity of frequently targeted OLPs in HLA-B1302+ subjects
were located in Gag and Pol (7 of top 9 responses; avg.
753 spot forming cells (SFC/106 PBMC). In addition, we
found frequent (avg. 58% recognition) and strong (avg.
872 SFC) responses against 3 of 6 previously described
clade C HLA-B1302 epitopes in Gag and Pol (Gag-VV9,
Pol-GI9, and Gag-RI9), versus infrequent (avg. 12% recog-
nition) and weak (avg. 316 SFC) responses to the other
described epitopes in Pol, Nef and Gag (Pol-RI10, Nef-
GI11, Gag-GI11). In analyzing for CTL escape mutations
in the 3 targeted epitopes or OLPs in Gag, we found no
evidence of viral escape.
Conclusion
HLA-B1302 is correlated with virus control in CRF01_AE
infection and appears to predominantly target highly con-
served regions of Gag and Pol. These data extend the
observation that maintenance of CD8+ T-cell responses
against highly conserved regions of HIV may also be criti-
cal to long-term control of CRF01_AE.
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